President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...

Nifty Pharma took a beating on Friday declining over four per cent, after Donald Trump hinted at a separate tariff for ...

To be sure, some goods will not be subject to the reciprocal tariff. They include steel and aluminum articles and autos and ...

VanEck Pharma ETF (PPH) which represents Big Pharma rises despite ongoing industry specific challenges as pharmaceuticals are ...

Bangalore: AstraZeneca Pharma India Limited has announced that the Company will be discontinuing the manufacturing and ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.

But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in February to impose “25% or higher” levies on imported drugs.

Tariffs will trigger some job losses, and impact future investment, but Ireland’s strategic value remains solid - ‘Pharma isn ...